Compound Radar

Insulet Corporation (PODD) Stock Analysis

United States · Healthcare / Medical Devices

Price $142.28
Market cap $9.87B
Next earnings Nov 5, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

80
80/100 Elite Quality
  • Financial Health 75
  • Profitability 95
  • Business Quality 75
  • Balance Sheet 65
  • Cash Flow 80

Why this rating?

Health 80/100 — Elite Quality

Strongest Profitability 95/100
Softest Balance Sheet 65/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Insulet Corporation (PODD) is a Medical Devices company in the Healthcare sector. Compound Radar rates Insulet Corporation 80/100 (Elite Quality) due to high business quality, strong revenue growth, and manageable leverage.

Investment profile

  • Quality High
  • Growth Strong
  • Balance Sheet Adequate
  • Valuation Fair

Financial highlights

Valuation

  • P/E 26.64
  • Forward P/E 18.45
  • PEG 1.16
  • EV/Revenue 3.49

Profitability

  • Revenue Growth 23.5%
  • Gross Margin 71.1%
  • Operating Margin 16.2%
  • Net Margin 12.3%
  • ROE 26.0%

Financial strength

  • Cash $534.90M
  • Debt $948.40M
  • Net Cash $-413.50M
  • Free Cash Flow $349.90M
  • Current Ratio 2.49

Similar companies

Peers in Medical Devices, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Devices →

FAQ

How Compound Radar scores and tracks Insulet Corporation (PODD).

View Methodology & FAQ →